2026 Mathieu Vinken: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	60	11860	10923	216	198	324	14484

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

11860

10923

216

198

324

14484

Biology and Biochemistry

D-Index

Citations

14484

World Ranking

11860

National Ranking

216

Overview

Mathieu Vinken is affiliated with the Vrije Universiteit Brussel in Belgium and has a significant body of research primarily in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their scholarly contributions span a range of topics and subfields, highlighting a focus on molecular and pharmacological aspects of liver and toxicology sciences.

Their research often appears in established scientific venues. Frequent publication outlets include Toxicology Letters, with 24 publications; Archives of Toxicology, totaling 15 papers; ALTEX, with 12 publications; International Journal of Molecular Sciences, featuring 9 papers; and Toxicology, also with 9 publications.

Vinken's main fields of study are Medicine and Biochemistry, Genetics, and Molecular Biology, with notable subfields such as Molecular Biology, Pharmacology, Epidemiology, Computational Theory and Mathematics, and Hepatology. This scientific focus is reflected in the main topics of their work:

Connexins and lens biology
Computational Drug Discovery Methods
Drug-Induced Hepatotoxicity and Protection
Liver Disease Diagnosis and Treatment
Animal testing and alternatives
Drug Transport and Resistance Mechanisms
Liver physiology and pathology

Mathieu Vinken has coauthored extensively with several researchers including Julen Sanz-Serrano, Raf Van Campenhout, Bruno Cogliati, Lindsey Devisscher, and M Cronin, reflecting collaborative work in toxicology and molecular biology.

Selected recent publications exemplify the range and focus of their work:

"New approach methodologies in human regulatory toxicology - Not if, but how and when!", 2023, published in Environment International
"Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods", 2022, published in International Journal of Molecular Sciences
"Safer chemicals using less animals: kick-off of the European ONTOX project", 2021, published in Toxicology
"Mechanisms Underlying Connexin Hemichannel Activation in Disease", 2021, published in International Journal of Molecular Sciences
"Rodent models of cholestatic liver disease: A practical guide for translational research", 2021, published in Liver International

Best Publications

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Patricio Godoy;Nicola J. Hewitt;Ute Albrecht;Melvin E. Andersen

1158
Citations
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

Sarah Adler;David Basketter;Stuart Creton;Olavi Pelkonen

631
Citations
The adverse outcome pathway concept: A pragmatic tool in toxicology

Mathieu Vinken

511
Citations
Adverse outcome pathways: opportunities, limitations and open questions.

Marcel Leist;Ahmed Ghallab;Ahmed Ghallab;Rabea Graepel;Rosemarie Marchan

378
Citations
Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures

Greetje Elaut;Tom Henkens;Peggy Papeleu;Sarah Snykers

375
Citations
Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction.

Danny Bavli;Sebastian Prill;Elishai Ezra;Gahl Levy

326
Citations
Experimental models of liver fibrosis

Sara Crespo Yanguas;Bruno Cogliati;Joost Willebrords;Michaël Maes

324
Citations
Connexins and their channels in cell growth and cell death

Mathieu Vinken;Tamara Vanhaecke;Peggy Papeleu;Sarah Snykers

318
Citations
Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury.

Nan Wang;Elke De Vuyst;Raf Ponsaerts;Kerstin Boengler

293
Citations
Connexin-related signaling in cell death: to live or let die?

E Decrock;M Vinken;E De Vuyst;D V Krysko

285
Citations
Ca2+ regulation of connexin 43 hemichannels in C6 glioma and glial cells

Elke De Vuyst;Nan Wang;Elke Decrock;Marijke De Bock

240
Citations
Experimental models of hepatotoxicity related to acute liver failure

Michaël Maes;Mathieu Vinken;Hartmut Jaeschke

224
Citations
Paracrine signaling through plasma membrane hemichannels.

Nan Wang;Marijke De Bock;Elke Decrock;Mélissa Bol

223
Citations
Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model.

E. Decrock;E. De Vuyst;M. Vinken;M. Van Moorhem

209
Citations
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research

Joost Willebrords;Isabel Veloso Alves Pereira;Michaël Maes;Sara Crespo Yanguas

186
Citations
Connexin Channels Provide a Target to Manipulate Brain Endothelial Calcium Dynamics and Blood—Brain Barrier Permeability

Marijke De Bock;Maxime Culot;Nan Wang;Mélissa Bol

176
Citations
Isolation of rat hepatocytes.

Peggy Papeleu;Tamara Vanhaecke;Tom Henkens;Greetje Elaut

173
Citations
Inhibitors of connexin and pannexin channels as potential therapeutics.

Joost Willebrords;Michaël Maes;Sara Crespo Yanguas;Mathieu Vinken

170
Citations
Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies

J. Fraczek;J. Bolleyn;T. Vanhaecke;V. Rogiers

148
Citations
Pannexin channels in ATP release and beyond: an unexpected rendezvous at the endoplasmic reticulum.

Catheleyne D'hondt;Raf Ponsaerts;Humbert De Smedt;Mathieu Vinken

145
Citations